生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Daptomycin exhibits strong in vitro inhibitory and bactericidal activity against a range of bacterial strains. It is notably effective against nafcillin-susceptible and resistant staphylococci with a MIC90 (minimum inhibitory concentration for 90% of organisms) of ≤0.5 mg/L, and against enterococci with a MIC90 of ≤2.0 mg/L. Daptomycin demonstrates greater efficacy than vancomycin against most isolates tested. It stands out as the most potent agent against nafcillin-resistant staphylococci and ranks among the most effective treatments for enterococci, excluding trimethoprim-sulfamethoxazole. Notably, both daptomycin and vancomycin exhibit an increase in MIC when the bacterial inoculum is increased from 105 to 107 nM cfu/mL, suggesting a dose-dependent response to larger bacterial populations[1]. Daptomycin's efficacy is contained within a relatively narrow concentration range, from 0.125 to 2.0 mg/mL, showing higher activity compared to other agents tested against S. faecalis [2]. Additionally, daptomycin has been found to inhibit the formation of nucleotide-linked intermediates in bacterial biosynthetic processes[3]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
0.62mL 0.12mL 0.06mL |
3.09mL 0.62mL 0.31mL |
6.17mL 1.23mL 0.62mL |
参考文献 |
---|